Bring Joy to Life, One Baby at a Time
Infertility as an Epidemic
Infertility is defined as failing to get pregnant after 2 years of marriage and regular sexual activity. The number of people dealing with infertility is increasing, estimated at 1 out of 10 couples.
Although IVF (in vitro fertilization) is a solution, IVF's success rate is only 40%. This low success rate is primarily attributed to the low quality and quantity of eggs and sperm available from donors. Western medicine does not offer a good solution for improving the quality and quantity of eggs and sperm.
Shawkea T-1, the Magic Bullet for InfertilityNow a brilliantly effective and safe alternative, that has benefited hundreds of thousands of patients in Japan, is now available in the United States! Shawkea TS•1 has been approved by the Japanese Food Authority based on solid scientific research and clinical observations. TS•1's efficacy and safety have been proved time and again by patients in Japan.
Intended Users of Shawkea T-1
1. Females with hormonal imbalance issues
2. Females with multiple miscarriages
3. Females with poor egg quality, such as being too small or malnourished
3. Females with endometria that is either too think or too thick for proper implantation
4. Females with PCOS
5. Females with severe menstrual pains
6. Females with irregular menstruation
7. Females with uterine fibroid
8. Females with gestational diabetes
9. Males with low sperm concentration, low motility and high defect rate
Shawkea T-1 is particularly effective as an adjuvant for in vitro fertilization (IVF) patients. Shawkea T-1 has repeatedly demonstrated its capability of increasing the quantity of eggs ovulated and sperms produced and, equally important, improving the quality of the eggs and sperms. In follow-up studies in Japan, a total of 177 patients who were undergoing IVF procedures were followed. These patients were using the standard IVF procedures such as hMG treatment, IVF, and ICSI. In addition, some patients were taking the Shawkea T-1 regimen as well. After six months of T-1 usage, the pregnancy rate in this group reached 70%. In contrast, the control group who had not used Shawkea TS•1, the pregnancy rate was only 45%.
